188 related articles for article (PubMed ID: 23489718)
1. A highly conserved mycobacterial cholesterol catabolic pathway.
García-Fernández E; Frank DJ; Galán B; Kells PM; Podust LM; García JL; Ortiz de Montellano PR
Environ Microbiol; 2013 Aug; 15(8):2342-59. PubMed ID: 23489718
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 125A4, the Third Cholesterol C-26 Hydroxylase from Mycobacterium smegmatis.
Frank DJ; Waddling CA; La M; Ortiz de Montellano PR
Biochemistry; 2015 Nov; 54(46):6909-16. PubMed ID: 26522442
[TBL] [Abstract][Full Text] [Related]
3. Functional redundancy of steroid C26-monooxygenase activity in Mycobacterium tuberculosis revealed by biochemical and genetic analyses.
Johnston JB; Ouellet H; Ortiz de Montellano PR
J Biol Chem; 2010 Nov; 285(47):36352-60. PubMed ID: 20843794
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol ester oxidation by mycobacterial cytochrome P450.
Frank DJ; Madrona Y; Ortiz de Montellano PR
J Biol Chem; 2014 Oct; 289(44):30417-30425. PubMed ID: 25210044
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterial cytochrome p450 125 (cyp125) catalyzes the terminal hydroxylation of c27 steroids.
Capyk JK; Kalscheuer R; Stewart GR; Liu J; Kwon H; Zhao R; Okamoto S; Jacobs WR; Eltis LD; Mohn WW
J Biol Chem; 2009 Dec; 284(51):35534-42. PubMed ID: 19846551
[TBL] [Abstract][Full Text] [Related]
6. The Structures of the Steroid Binding CYP142 Cytochrome P450 Enzymes from
Ghith A; Doherty DZ; Bruning JB; Russell RA; De Voss JJ; Bell SG
ACS Infect Dis; 2022 Aug; 8(8):1606-1617. PubMed ID: 35881654
[TBL] [Abstract][Full Text] [Related]
7. Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.
Driscoll MD; McLean KJ; Levy C; Mast N; Pikuleva IA; Lafite P; Rigby SE; Leys D; Munro AW
J Biol Chem; 2010 Dec; 285(49):38270-82. PubMed ID: 20889498
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest-4-en-3-one.
Ouellet H; Guan S; Johnston JB; Chow ED; Kells PM; Burlingame AL; Cox JS; Podust LM; de Montellano PR
Mol Microbiol; 2010 Aug; 77(3):730-42. PubMed ID: 20545858
[TBL] [Abstract][Full Text] [Related]
9. A comparison of steroid and lipid binding cytochrome P450s from Mycobacterium marinum and Mycobacterium tuberculosis.
Child SA; Ghith A; Bruning JB; Bell SG
J Inorg Biochem; 2020 Aug; 209():111116. PubMed ID: 32473484
[TBL] [Abstract][Full Text] [Related]
10. ChoD and HsdD can be dispensable for cholesterol degradation in mycobacteria.
Brzostek A; Rumijowska-Galewicz A; Dziadek B; Wojcik EA; Dziadek J
J Steroid Biochem Mol Biol; 2013 Mar; 134():1-7. PubMed ID: 23064392
[TBL] [Abstract][Full Text] [Related]
11. Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.
Ortiz de Montellano PR
J Inorg Biochem; 2018 Mar; 180():235-245. PubMed ID: 29352597
[TBL] [Abstract][Full Text] [Related]
12. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes.
McLean KJ; Marshall KR; Richmond A; Hunter IS; Fowler K; Kieser T; Gurcha SS; Besra GS; Munro AW
Microbiology (Reading); 2002 Oct; 148(Pt 10):2937-2949. PubMed ID: 12368427
[TBL] [Abstract][Full Text] [Related]
13. Substrate analog studies of the ω-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1.
Johnston JB; Singh AA; Clary AA; Chen CK; Hayes PY; Chow S; De Voss JJ; Ortiz de Montellano PR
Bioorg Med Chem; 2012 Jul; 20(13):4064-81. PubMed ID: 22647881
[TBL] [Abstract][Full Text] [Related]
14. The oxidation of cholesterol derivatives by the CYP124 and CYP142 enzymes from Mycobacterium marinum.
Ghith A; Bruning JB; Bell SG
J Steroid Biochem Mol Biol; 2023 Jul; 231():106317. PubMed ID: 37141947
[TBL] [Abstract][Full Text] [Related]
15. The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.
McLean KJ; Lafite P; Levy C; Cheesman MR; Mast N; Pikuleva IA; Leys D; Munro AW
J Biol Chem; 2009 Dec; 284(51):35524-33. PubMed ID: 19846552
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol Analogs with Degradation-resistant Alkyl Side Chains Are Effective Mycobacterium tuberculosis Growth Inhibitors.
Frank DJ; Zhao Y; Wong SH; Basudhar D; De Voss JJ; Ortiz de Montellano PR
J Biol Chem; 2016 Apr; 291(14):7325-33. PubMed ID: 26833565
[TBL] [Abstract][Full Text] [Related]
17. Identification, characterization, and azole-binding properties of Mycobacterium smegmatis CYP164A2, a homolog of ML2088, the sole cytochrome P450 gene of Mycobacterium leprae.
Warrilow AG; Jackson CJ; Parker JE; Marczylo TH; Kelly DE; Lamb DC; Kelly SL
Antimicrob Agents Chemother; 2009 Mar; 53(3):1157-64. PubMed ID: 19075057
[TBL] [Abstract][Full Text] [Related]
18. Mycofactocin Is Associated with Ethanol Metabolism in Mycobacteria.
Krishnamoorthy G; Kaiser P; Lozza L; Hahnke K; Mollenkopf HJ; Kaufmann SHE
mBio; 2019 May; 10(3):. PubMed ID: 31113891
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis CYP130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs.
Ouellet H; Podust LM; de Montellano PR
J Biol Chem; 2008 Feb; 283(8):5069-80. PubMed ID: 18089574
[TBL] [Abstract][Full Text] [Related]
20. Regulation Mechanism of the ald Gene Encoding Alanine Dehydrogenase in Mycobacterium smegmatis and Mycobacterium tuberculosis by the Lrp/AsnC Family Regulator AldR.
Jeong JA; Hyun J; Oh JI
J Bacteriol; 2015 Oct; 197(19):3142-53. PubMed ID: 26195594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
